Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation

Detalles Bibliográficos
Autores principales: Yang, Jie, Yang, Jun-Jun, Zhao, Jun, Ren, Tong, Feng, Feng-Zhi, Wan, Xi-Run, Xiang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Clinical Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421185/
https://www.ncbi.nlm.nih.gov/pubmed/28469110
http://dx.doi.org/10.4103/0366-6999.204922
_version_ 1783234552764825600
author Yang, Jie
Yang, Jun-Jun
Zhao, Jun
Ren, Tong
Feng, Feng-Zhi
Wan, Xi-Run
Xiang, Yang
author_facet Yang, Jie
Yang, Jun-Jun
Zhao, Jun
Ren, Tong
Feng, Feng-Zhi
Wan, Xi-Run
Xiang, Yang
author_sort Yang, Jie
collection PubMed
description
format Online
Article
Text
id pubmed-5421185
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54211852017-05-24 Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation Yang, Jie Yang, Jun-Jun Zhao, Jun Ren, Tong Feng, Feng-Zhi Wan, Xi-Run Xiang, Yang Chin Med J (Engl) Clinical Practice Medknow Publications & Media Pvt Ltd 2017-05-05 /pmc/articles/PMC5421185/ /pubmed/28469110 http://dx.doi.org/10.4103/0366-6999.204922 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Clinical Practice
Yang, Jie
Yang, Jun-Jun
Zhao, Jun
Ren, Tong
Feng, Feng-Zhi
Wan, Xi-Run
Xiang, Yang
Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation
title Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation
title_full Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation
title_fullStr Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation
title_full_unstemmed Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation
title_short Unusual Ovarian Cancer Relapse Managed by Nivolumab in a Long-term Surviving Patient with PD-L1 Mutation
title_sort unusual ovarian cancer relapse managed by nivolumab in a long-term surviving patient with pd-l1 mutation
topic Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421185/
https://www.ncbi.nlm.nih.gov/pubmed/28469110
http://dx.doi.org/10.4103/0366-6999.204922
work_keys_str_mv AT yangjie unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation
AT yangjunjun unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation
AT zhaojun unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation
AT rentong unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation
AT fengfengzhi unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation
AT wanxirun unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation
AT xiangyang unusualovariancancerrelapsemanagedbynivolumabinalongtermsurvivingpatientwithpdl1mutation

Ejemplares similares